# Efficacy of Retinal Nerve Fiber Layer (RNFL) / Retinal Thickness Ratio by Cirrus OCT Utilizing Spectral -Domain Technology as a Diagnostic Predictor of Glaucoma

> **NCT00772993** · — · UNKNOWN · sponsor: **Yonsei University** · enrollment: 400 (estimated)

## Conditions studied

- Glaucoma
- Myopia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00772993
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-10
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2008-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00772993

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00772993, "Efficacy of Retinal Nerve Fiber Layer (RNFL) / Retinal Thickness Ratio by Cirrus OCT Utilizing Spectral -Domain Technology as a Diagnostic Predictor of Glaucoma". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00772993. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*